Literature DB >> 1915565

Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant.

J B Warren1, L E Donnelly, S Cullen, B E Robertson, M A Ghatei, S R Bloom, J MacDermot.   

Abstract

The vasoactivity of the 27- and 38-amino acid forms of the novel peptide pituitary adenylate cyclase-activating polypeptide (PACAP) was tested in vitro. Both forms of PACAP caused endothelium-independent vasodilation (assayed by their vasodilator action on rabbit aorta). When superfused for 1 min the relaxation EC50 of PACAP27 was 23 +/- 8 nM and of PACAP38 was 152 +/- 66 nM. PACAP was 100-fold more potent than vasoactive intestinal polypeptide (VIP) (PACAP27 shows 68% amino acid sequence homology with VIP), and had a prolonged duration of action, a 1 min exposure to 1 microM PACAP27 lasting 135 +/- 7 min and to 1 microM PACAP38 108 +/- 3 min. Adenylate cyclase activity in homogenates of rabbit aortic smooth muscle cells was increased by PACAP27 and PACAP38 with EC50s of 4.4 and 0.73 nM, respectively. PACAP27 and PACAP38 are potent, long-lasting, endothelium-independent vasodilators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915565     DOI: 10.1016/0014-2999(91)90511-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema.

Authors:  Zsuzsanna Helyes; Jozsef Kun; Nora Dobrosi; Katalin Sándor; Jozsef Németh; Aniko Perkecz; Erika Pintér; Krisztina Szabadfi; Balazs Gaszner; Valeria Tékus; Janos Szolcsányi; Martin Steinhoff; Hitoshi Hashimoto; Dora Reglődi; Tamas Bíró
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

2.  Pituitary adenylate cyclase activating peptides relax human pulmonary arteries by opening of KATP and KCa channels.

Authors:  L Bruch; S Rubel; A Kästner; K Gellert; M Gollasch; C Witt
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 3.  Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?

Authors:  Eva V L Roloff; Ana M Tomiak-Baquero; Sergey Kasparov; Julian F R Paton
Journal:  J Physiol       Date:  2016-10-05       Impact factor: 5.182

4.  Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.

Authors:  Eszter Banki; Danuta Sosnowska; Zsuzsanna Tucsek; Tripti Gautam; Peter Toth; Stefano Tarantini; Andrea Tamas; Zsuzsanna Helyes; Dora Reglodi; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-18       Impact factor: 6.053

5.  Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wall.

Authors:  Tom Ziessen; Salvador Moncada; Selim Cellek
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.

Authors:  K M Braas; V May; S A Harakall; J C Hardwick; R L Parsons
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

7.  Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.

Authors:  Zoltan Vamos; Ivan Ivic; Peter Cseplo; Gabor Toth; Andrea Tamas; Dora Reglodi; Akos Koller
Journal:  J Mol Neurosci       Date:  2014-06-19       Impact factor: 3.444

8.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion.

Authors:  Peter Szakaly; Peter Kiss; Andrea Lubics; Tamas Magyarlaki; Andrea Tamas; Boglarka Racz; Istvan Lengvari; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-05-14       Impact factor: 3.444

10.  Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.

Authors:  J B Warren; S W Larkin; M Coughlan; R Kajekar; T J Williams
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.